skip to content

Cambridge Global Challenges

 

The UK government has announced that it will be committing over £30 million of funding and will continue to lead the global fight against antimicrobial resistance. The funding will be delivered via four new projects as part of the Global AMR Innovation Fund (GAMRIF).

The UK government's Global AMR Innovation Fund is providing seed funding for innovative research and development to tackle the growing threat of AMR globally. This funding will be targeted in low and middle income countries (LMICs) where the burden is greatest and is crucial for the health and economic prosperity of the world's poorest.

The new projects are:

  • Committing £20 million to the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).
  • Providing £5 million for a new bilateral partnership with Argentina supporting research to tackle AMR in agriculture and the impact on the environment. 
  • Investing £5 million in the Foundation for Innovative New Diagnostics (FIND). 
  • Investing £1 million in the Global Antibiotic Research & Development Partnership (GARDP). 

 

The full press release can be accessed on the NERC website.

 

 

Cambridge Global Challenges is a Strategic Research Initiative of the University of Cambridge that aims to enhance the contribution of its research towards addressing global challenges and achieving the Sustainable Development Goals (SDGs) by 2030.

Funding Opportunities

Find out about open funding opportunities, pre-call announcements, responsive calls, studentships and awards relevant to the global...